Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
Hum Mutat. 2020 May;41(5):973-982. doi: 10.1002/humu.23986. Epub 2020 Feb 6.
Gastrointestinal motility disorders include a spectrum of mild to severe clinical phenotypes that are caused by smooth muscle dysfunction. We investigated the genetic etiology of severe esophageal, gastric, and colonic dysmotility in two unrelated families with autosomal dominant disease presentation. Using exome sequencing, we identified a 2 base pair insertion at the end of the myosin heavy chain 11 (MYH11) gene in all affected members of Family 1 [NM_001040113:c.5819_5820insCA(p.Gln1941Asnfs91)] and a 1 base pair deletion at the same genetic locus in Proband 2 [NM_001040113:c.5819del(p.Pro1940Hisfs91)]. Both variants are predicted to result in a similarly elongated protein product. Heterozygous dominant negative MYH11 pathogenic variants have been associated with thoracic aortic aneurysm and dissection while biallelic null alleles have been associated with megacystis microcolon intestinal hypoperistalsis syndrome. This report highlights heterozygous protein-elongating MYH11 variants affecting the SM2 isoforms of MYH11 as a cause for severe gastrointestinal dysmotility, and we hypothesize that the mechanistic pathogenesis of this disease, dominant hypercontractile loss-of-function, is distinct from those implicated in other diseases involving MYH11 dysfunction.
胃肠道动力障碍包括一系列由平滑肌功能障碍引起的从轻度到重度的临床表型。我们研究了两个不相关的常染色体显性疾病家族中严重食管、胃和结肠动力障碍的遗传病因。使用外显子组测序,我们在家族 1 的所有受影响成员中发现了肌球蛋白重链 11 (MYH11) 基因末端的 2 个碱基插入[NM_001040113:c.5819_5820insCA(p.Gln1941Asnfs91)],并在 2 号先证者中发现了相同遗传位置的 1 个碱基缺失[NM_001040113:c.5819del(p.Pro1940Hisfs91)]。这两种变体预计都会导致蛋白产物类似地延长。杂合的显性负性 MYH11 致病性变体与胸主动脉瘤和夹层有关,而双等位基因的无效等位基因与巨膀胱微结肠肠蠕动不良综合征有关。本报告强调了影响 MYH11 的 SM2 同工型的异质蛋白延长 MYH11 变体是严重胃肠道动力障碍的原因,我们假设这种疾病的机械发病机制,即显性高收缩性功能丧失,与涉及 MYH11 功能障碍的其他疾病不同。